Persistence and clearance of SARS-CoV-2
Persistence and clearance of SARS-CoV-2. Heneghan C.
https://www.cebm.net/study/persistence-and-clearance-of-sars-cov-2/
Published on July 30, 2020
Included in
Transmission Dynamics of COVID-19
Reference |
Ling Y, Xu SB, Lin YX, et al. Persitance and clearance of viral RNA in 2019 novel coronavirus disease rehabilitation patients. Chin Med J (Engl). 2020;133(9):1039-1043. doi:10.1097/CM9.0000000000000774 |
Study type |
|
Country |
China |
Setting |
Hospital |
Funding Details |
First-class university and first-class discipline building project of the Fudan University and the Scientific research for special subjects on 2019 novel coronavirus of the Shanghai Public Health Clinical Center. |
Transmission mode |
Orofecal |
Exposures |
|
Bottom Line
Clearance of viral RNA in patients’ stools was delayed compared to oropharyngeal swabs.
Evidence Summary
From 292 confirmed cases, 66 recovered patients were included, and 28 (42%) analyzed. By February 10th, 11 convalescent patients (17%) still tested positive for viral RNA from stool specimens – the other 55 patients’ stool specimens were negative following a median duration of 11.0 (9.0–16.0) days after symptom onset.
Duration of viral RNA detection from oropharyngeal swabs and fecal samples was longer in thos
What did they do?
From January 20, 2020, to February 10, 2020, all confirmed patients with COVID-19 in the Shanghai region were admitted to the Shanghai Public Health Clinical Center.
The clinical data and laboratory test results for patients admitted from January 20th to February 10th 2020 were collected retrospectively. RT-PCR results for patients’ oropharyngeal swab, stool, urine, and serum samples were collected and analysed
Study reliability
Clearly defined setting |
Demographic characteristics described |
Follow-up length was sufficient |
Transmission outcomes assessed |
Main biases are taken into consideration |
Yes |
Partly |
Yes |
Yes
|
No |
What else should I consider?
About the authors
Carl Heneghan
Carl is Professor of EBM & Director of CEBM at the University of Oxford. He is also a GP and tweets @carlheneghan. He has an active interest in discovering the truth behind health research findings